Sertraline Austell 50 mg/ 100 mg FC tablets
PDF Leaflet Revision Date: 21 June 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of major depressive disorders, OCD, and panic disorder.
Dosage (summary)
Starting dose 50 mg daily; may increase to 150-200 mg for difficult cases.
Onset of Action / Duration
Onset: 7 days, Duration: 24 hours
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not established; avoid breastfeeding.
Key Drug Interactions
- MAOIs
- Pimozide
- CYP2D6 substrates
Contraindications
- Hypersensitivity
- MAOI use
- Hepatic impairment
- Renal impairment
Common side effects
- Nausea
- Dizziness
- Insomnia
- Sexual dysfunction
Counselling Points
- Monitor for worsening symptoms
- Avoid alcohol
- Taper off to discontinue
Serious warnings
- Serotonin syndrome
- Suicidal thoughts
- QTc prolongation
Important Disclaimer
The Sertraline Austell 50 mg/ 100 mg FC tablets professional information leaflet below is the property of Austell Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
